Is GLP-1 Safe for Long-Term Weight Loss
Current research explores roles in diabetes, heart health, and neurodegeneration
Clinical trials measuring body composition found that fat mass reduction occurred without corresponding increases in lean tissue mass, confirming the absence of anabolic muscle-building effects
Dokken BB, La Bonte LR, Davis-Gorman G, Teachey MK, Seaver N, McDonagh PF: Glucagon-like peptide-1 (GLP-1), immediately prior to reperfusion, decreases neutrophil activation and reduces myocardial infarct size in rodents
Cheaper obesity medications could come to Canada this summer, as Health Canada reviews generics More than a weight loss drug: the far-reaching effects of Ozempic on health and society "For individuals who do want to reduce or consider stopping the medication, what does that support look like?" said Reichert, who has consulted for makers of weight loss medications